MedTrace Logo

Natural Topical Treatment for Vulvar and Vaginal Atrophy

NCT05871255 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-11-13

No results posted yet for this study

Summary

Genitourinary syndrome of menopause (GSM) is a chronic and progressive syndrome characterized by a collection of genital and urinary signs and symptoms secondary to the state of hypoestrogenism related to menopause.

Conditions

  • Genitourinary Syndrome of Menopause

Interventions

OTHER

Zantogin® Gel

Zantogin® Gel (ZG) is a multicomponent vaginal lubricant endowed with lenitive and anti-inflammatory properties, developed as class II medical device for the treatment of VVA.

Sponsors & Collaborators

  • University of Roma La Sapienza

    collaborator OTHER

  • Dr. Amjad Khan

    lead OTHER

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-05
Primary Completion
2022-06-30
Completion
2023-04-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05871255 on ClinicalTrials.gov